• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸菌属对产碳青霉烯酶肠杆菌科的抗菌能力及机制分析。

Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae.

机构信息

Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan; Department of Food Science, National Chiayi University, Chiayi, Taiwan.

Department of Internal Medicine, Kaohsiung Veterans General Hospital Tainan Branch, Tainan, Taiwan.

出版信息

J Microbiol Immunol Infect. 2021 Jun;54(3):447-456. doi: 10.1016/j.jmii.2020.01.005. Epub 2020 Feb 15.

DOI:10.1016/j.jmii.2020.01.005
PMID:32102749
Abstract

BACKGROUND

This study aims to investigate the antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae (CPE).

METHODS

Five Lactobacillus spp. strains and 18 CPE clinical isolates were collected. Their anti-CPE effects were assessed by agar well diffusion and broth microdilution assay, as well as time-kill test. Finally, the specific anti-CPE mechanism, especially for the effect of organic acids was determined using broth microdilution method.

RESULTS

All of five Lactobacilli isolates displayed the potent activity against most CPE isolates with mean zones of inhibition ranging 10.2-21.1 mm. The anti-CPE activity was not affected by heating, catalase, and proteinase treatment. Under the concentration of 50% LUC0180 cell-free supernatant (CFS), lactic acid, and mix acid could totally inhibit the growth of carbapenem-resistant Klebsiella pneumoniae (CPE0011), and acetic acid could inhibit 67.8%. In contrast, succinic acid and citric acid could not inhibit the growth of CPE0011. While we decreased the concentration to 25%, only lactic acid and mix acid displayed 100% inhibition. In contrast, succinic acid, citric acid and acetic acid did not show any inhibitory effect.

CONCLUSIONS

Lactobacillus strains exhibit potent anti-CPE activity, and lactic acid produced by Lactobacillus strains is the major antimicrobial mechanism.

摘要

背景

本研究旨在探讨乳酸菌属对产碳青霉烯酶肠杆菌科(CPE)的抗菌能力和机制分析。

方法

收集了 5 株乳酸菌和 18 株 CPE 临床分离株。通过琼脂孔扩散和肉汤微量稀释法以及时间杀伤试验评估它们对 CPE 的抑制作用。最后,使用肉汤微量稀释法确定特定的抗 CPE 机制,特别是有机酸的作用。

结果

所有 5 株乳酸菌分离株对大多数 CPE 分离株均表现出强大的活性,平均抑菌环直径为 10.2-21.1mm。加热、过氧化氢酶和蛋白酶处理并不影响其抗 CPE 活性。在 50%LUC0180 无细胞上清液(CFS)、乳酸和混合酸浓度下,可完全抑制耐碳青霉烯类肺炎克雷伯菌(CPE0011)的生长,而乙酸可抑制 67.8%。相比之下,琥珀酸和柠檬酸不能抑制 CPE0011 的生长。当我们将浓度降低至 25%时,只有乳酸和混合酸显示出 100%的抑制作用。相比之下,琥珀酸、柠檬酸和乙酸没有显示出任何抑制作用。

结论

乳酸菌株具有强大的抗 CPE 活性,而乳酸菌株产生的乳酸是主要的抗菌机制。

相似文献

1
Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae.乳酸菌属对产碳青霉烯酶肠杆菌科的抗菌能力及机制分析。
J Microbiol Immunol Infect. 2021 Jun;54(3):447-456. doi: 10.1016/j.jmii.2020.01.005. Epub 2020 Feb 15.
2
Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.采用小鼠大腿感染模型,对美罗培南、头孢吡肟或氨曲南与新型β-内酰胺酶抑制剂那库巴坦联合用药,针对耐碳青霉烯类和/或产碳青霉烯酶的肺炎克雷伯菌和大肠埃希菌进行药效学评价。
Int J Antimicrob Agents. 2021 May;57(5):106330. doi: 10.1016/j.ijantimicag.2021.106330. Epub 2021 Mar 28.
3
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .头孢他啶-阿维巴坦对产碳青霉烯酶的. 的体外和体内杀菌活性。
Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.
4
In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains.体内研究评估了美罗培南和阿米卡星联合治疗对耐碳青霉烯类和产碳青霉烯酶肠杆菌科菌株的效果。
J Infect Chemother. 2020 Jan;26(1):1-7. doi: 10.1016/j.jiac.2019.10.014. Epub 2019 Nov 15.
5
Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.2006 年至 2015 年日本医院中产碳青霉烯酶肠杆菌科的趋势和分子特征。
J Infect Chemother. 2020 Jul;26(7):667-671. doi: 10.1016/j.jiac.2020.02.002. Epub 2020 Mar 26.
6
Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.2015 年至 2017 年间,泰国曼谷诗里拉吉医院定植患者的产多药耐药碳青霉烯酶 ST231 和 ST16 肺炎克雷伯菌的基因组和临床特征。
BMC Infect Dis. 2021 Feb 4;21(1):142. doi: 10.1186/s12879-021-05790-9.
7
Emergence of extended-spectrum β-lactamase (ESBL) and/or carbapenemase producing Enterobacteriaceae (CPE) and their antimicrobial resistance.产超广谱β-内酰胺酶(ESBL)和/或碳青霉烯酶的肠杆菌科细菌(CPE)的出现及其抗菌耐药性。
Bratisl Lek Listy. 2019;120(12):935-940. doi: 10.4149/BLL_2019_157.
8
An agar plate-based modified carbapenem inactivation method (p-mCIM) for detection of carbapenemase-producing Enterobacteriaceae.基于琼脂平板的改良碳青霉烯失活法(p-mCIM)用于检测产碳青霉烯酶肠杆菌科。
J Microbiol Methods. 2020 Jan;168:105781. doi: 10.1016/j.mimet.2019.105781. Epub 2019 Nov 20.
9
Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.碳青霉烯类药物暴露前史是产非碳青霉烯酶类碳青霉烯耐药肠杆菌科和产碳青霉烯酶肠杆菌科的危险因素。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00845-19. Print 2019 Oct.
10
Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.头孢他啶-阿维巴坦对西班牙感染-碳青霉烯类耐药评估监测试验(iCREST)中尿液标本中产碳青霉烯酶肠杆菌科的活性。
Int J Antimicrob Agents. 2018 Mar;51(3):511-515. doi: 10.1016/j.ijantimicag.2018.01.011. Epub 2018 Jan 31.

引用本文的文献

1
Isolation and characterization of GX0002947 from naturally fermented sour porridge and its application in cereal fermentation.从自然发酵酸粥中分离并鉴定GX0002947及其在谷物发酵中的应用
Front Microbiol. 2025 Mar 31;16:1563733. doi: 10.3389/fmicb.2025.1563733. eCollection 2025.
2
Antibacterial and Anti-virulence Properties of Cell-free Supernatant from a Mixture of Limosilactobacillus fermentum Strains Against Enterotoxigenic Escherichia coli.发酵乳杆菌菌株混合物的无细胞上清液对产肠毒素大肠杆菌的抗菌及抗毒力特性
Probiotics Antimicrob Proteins. 2025 Mar 10. doi: 10.1007/s12602-025-10509-2.
3
Comprehensive genomics, probiotic, and antibiofilm potential analysis of Streptococcus thermophilus strains isolated from homemade and commercial dahi.
对从自制和市售达希中分离出的嗜热链球菌菌株进行全面的基因组学、益生菌和抗生物膜潜力分析。
Sci Rep. 2025 Feb 27;15(1):7089. doi: 10.1038/s41598-025-90999-w.
4
Cell-free supernatant of 1A-TV shows a promising activity to eradicate carbapenem-resistant colonization.1A-TV的无细胞上清液在根除耐碳青霉烯类定植方面显示出有前景的活性。
Front Cell Infect Microbiol. 2024 Dec 3;14:1471107. doi: 10.3389/fcimb.2024.1471107. eCollection 2024.
5
Inhibitory Potential of FB1-1 Cell-Free Supernatant against Carbapenem-Resistant Drug Resistance Spread.FB1-1无细胞上清液对碳青霉烯耐药性传播的抑制潜力
Microorganisms. 2024 Jun 14;12(6):1203. doi: 10.3390/microorganisms12061203.
6
Clinical use of tigecycline may contribute to the widespread dissemination of carbapenem-resistant hypervirulent strains.替加环素的临床应用可能导致碳青霉烯类耐药高毒力菌株的广泛传播。
Emerg Microbes Infect. 2024 Dec;13(1):2306957. doi: 10.1080/22221751.2024.2306957. Epub 2024 Jan 30.
7
Revealing the Potential Impacts of Nutraceuticals Formulated with Freeze-Dried Jabuticaba Peel and Limosilactobacillus fermentum Strains Candidates for Probiotic Use on Human Intestinal Microbiota.揭示含有冻干巴西葡萄果皮和发酵乳杆菌菌株(候选益生菌)的营养保健品对人体肠道微生物群的潜在影响。
Probiotics Antimicrob Proteins. 2024 Oct;16(5):1773-1789. doi: 10.1007/s12602-023-10134-x. Epub 2023 Aug 10.
8
In Vitro Effect of the Cell-Free Supernatant of the Strain IMAU60214 against the Different Pathogenic Properties of Diarrheagenic .菌株IMAU60214的无细胞上清液对致泻性不同致病特性的体外作用
Microorganisms. 2023 May 18;11(5):1324. doi: 10.3390/microorganisms11051324.
9
Development and Characterization of Hydroxyethyl Cellulose-Based Gels Containing Lactobacilli Strains: Evaluation of Antimicrobial Effects in In Vitro and Ex Vivo Models.含乳酸杆菌菌株的羟乙基纤维素基凝胶的研制与表征:体外和离体模型中的抗菌效果评估
Pharmaceuticals (Basel). 2023 Mar 22;16(3):468. doi: 10.3390/ph16030468.
10
Gut-on-a-Chip for the Analysis of Bacteria-Bacteria Interactions in Gut Microbial Community: What Would Be Needed for Bacterial Co-Culture Study to Explore the Diet-Microbiota Relationship?肠道芯片用于分析肠道微生物群落中细菌-细菌相互作用:在细菌共培养研究中需要什么来探索饮食-微生物群关系?
Nutrients. 2023 Feb 23;15(5):1131. doi: 10.3390/nu15051131.